Literature DB >> 14653306

Functional neuroimaging of genetic variation in serotonergic neurotransmission.

A R Hariri1, D R Weinberger.   

Abstract

Serotonin (5-hydroxytryptamine; 5-HT) is a potent modulator of the physiology and behavior involved in generating appropriate responses to environmental cues such as danger or threat. Furthermore, genetic variation in 5-HT subsystem genes can impact upon several dimensions of emotional behavior including neuroticism and psychopathology, but especially anxiety traits. Recently, functional neuroimaging has provided a dramatic illustration of how a promoter polymorphism in the human 5-HT transporter (5-HTT) gene, which has been weakly related to these behaviors, is strongly related to the engagement of neural systems, namely the amygdala, subserving emotional processes. In this commentary, we discuss how functional neuroimaging can be used to characterize the effects of polymorphisms in 5-HT subsystem genes on the response of neural circuits underlying the generation and regulation of mood and temperament as well as susceptibility to affective illness. We argue that in time, such knowledge will allow us to not only transcend phenomenological diagnosis and represent mechanisms of disease, but also identify at-risk individuals and biological pathways for the development of new treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14653306     DOI: 10.1046/j.1601-1848.2003.00048.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  19 in total

1.  Gender differences in the genetic and environmental determinants of adolescent depression.

Authors:  Monica Uddin; Karestan C Koenen; Regina de Los Santos; Erin Bakshis; Allison E Aiello; Sandro Galea
Journal:  Depress Anxiety       Date:  2010-07       Impact factor: 6.505

2.  Imaging or imagining? A neuroethics challenge informed by genetics.

Authors:  Judy Illes; Eric Racine
Journal:  Am J Bioeth       Date:  2005       Impact factor: 11.229

3.  The BOLD signal in the amygdala does not differentiate between dynamic facial expressions.

Authors:  Christiaan van der Gaag; Ruud B Minderaa; Christian Keysers
Journal:  Soc Cogn Affect Neurosci       Date:  2007-06       Impact factor: 3.436

Review 4.  Pharmacogenetics in drug development.

Authors:  Alun D McCarthy; James L Kennedy; Lefkos T Middleton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

5.  Positive Emotion Regulation and Psychopathology: A Transdiagnostic Cultural Neuroscience Approach.

Authors:  Lisa A Hechtman; Hannah Raila; Joan Y Chiao; June Gruber
Journal:  J Exp Psychopathol       Date:  2013-05-13

6.  A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.

Authors:  Sean P David; Naga Venkatesha Murthy; Eugenii A Rabiner; Marcus R Munafó; Elaine C Johnstone; Robyn Jacob; Robert T Walton; Paul M Grasby
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 7.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

8.  Neuroimaging in psychiatry: from bench to bedside.

Authors:  David E J Linden; Andreas J Fallgatter
Journal:  Front Hum Neurosci       Date:  2009-12-23       Impact factor: 3.169

9.  COMT Val158Met polymorphism and socioeconomic status interact to predict attention deficit/hyperactivity problems in children aged 10-14.

Authors:  Maria Nobile; Marianna Rusconi; Monica Bellina; Cecilia Marino; Roberto Giorda; Ombretta Carlet; Laura Vanzin; Massimo Molteni; Marco Battaglia
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-11-28       Impact factor: 4.785

10.  Neuregulin-1 genotypes and eye movements in schizophrenia.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Andres Ingason; Samuel B Hutton; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-03       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.